Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes

OBJECTIVE: To determine the effect of tirzepatide, a dual agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 receptors, on biomarkers of nonalcoholic steatohepatitis (NASH) and fibrosis in patients with type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS: Pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartman, Mark L., Sanyal, Arun J., Loomba, Rohit, Wilson, Jonathan M., Nikooienejad, Amir, Bray, Ross, Karanikas, Chrisanthi A., Duffin, Kevin L., Robins, Deborah A., Haupt, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2020
Materias:
Novel Communications in Diabetes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245348/
https://www.ncbi.nlm.nih.gov/pubmed/32291277
http://dx.doi.org/10.2337/dc19-1892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245348/
https://www.ncbi.nlm.nih.gov/pubmed/32291277
http://dx.doi.org/10.2337/dc19-1892

Ejemplares similares